The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older and those 12 to ...

The U.S. Food and Drug Administration made a surprising move last week, announcing that the agency will limit the use of the ...

Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.

Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC ...

As the Trump administration moves to limit COVID booster vaccines for some, here's what to know about the latest variant NB.1 ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...

The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA ...

The Trump administration’s shift to narrow approval for coronavirus vaccines to only those who are at high risk for severe disease has raised concerns among Americans who came to rely on annual ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual restrictions. Novavax makes the nation’s only traditional protein-based ...

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay.